GUJARAT TERCE LABORATORIES
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Gujarat Terce Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
2.22₹ 0.98
As on Nov 13, 2025, 4:01 PM IST
Gujarat Terce Laboratories Price Performance
Today's LowToday's High
₹43.56₹46.49
₹45.03
52 Weeks' Low52 Weeks' High
₹37.20₹92.22
₹45.03
Open Price
₹45.00
Prev. Close
₹44.05
Volume
19,107
Over the last 5 years, the share price of Gujarat Terce Laboratories has gained 40.83% CAGR. Over the past year, the corresponding return has been -44.16%.
Gujarat Terce Laboratories’s current P/E of 0.00x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Gujarat Terce Laboratories Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Gujarat Terce Laboratories | 1.99 | -20.41 | 7.16 | -22.50 | -44.16 | 37.29 | 40.83 |
| Sun Pharmaceutical Industries | 3.23 | 4.30 | 6.14 | 2.34 | -2.20 | 19.63 | 27.90 |
| Divi's Laboratories | -4.31 | 0.54 | 7.97 | 8.55 | 14.14 | 26.21 | 13.94 |
| Torrent Pharmaceuticals | 7.82 | 8.88 | 5.93 | 18.57 | 22.74 | 32.48 | 22.95 |
| Cipla | 1.72 | -2.44 | -2.31 | 0.42 | 1.37 | 10.55 | 15.43 |
| Dr. Reddy's Laboratories | 2.49 | -2.14 | -1.40 | 2.34 | -0.86 | 12.25 | 4.93 |
| Zydus Lifesciences | 0.99 | -4.83 | -4.40 | 4.87 | -1.87 | 30.64 | 17.32 |
| Lupin | 4.80 | 4.05 | 3.06 | -0.63 | 0.55 | 39.23 | 17.86 |
| Mankind Pharma | -1.96 | -7.28 | -8.17 | -11.15 | -10.55 | 16.71 | 9.72 |
| Aurobindo Pharma | 5.73 | 6.08 | 11.95 | -1.35 | -3.48 | 35.25 | 7.04 |
| Alkem Laboratories | 1.26 | 3.94 | 6.01 | 11.53 | 2.53 | 21.97 | 16.35 |
| Abbott India | 0.14 | -1.47 | -10.51 | -2.97 | 6.78 | 13.94 | 13.94 |
| Biocon | 8.32 | 19.40 | 15.78 | 26.51 | 25.96 | 13.35 | -0.77 |
| Laurus Labs | 1.89 | 13.88 | 15.52 | 67.48 | 109.20 | 28.61 | 28.57 |
| Glenmark Pharmaceuticals | 3.63 | -1.82 | -7.65 | 32.46 | 21.96 | 63.33 | 31.00 |
| GlaxoSmithKline Pharmaceuticals | -4.11 | -9.28 | -10.02 | -10.55 | 1.73 | 23.16 | 11.84 |
| Anthem Biosciences | 0.26 | -11.03 | -7.48 | -4.40 | -4.40 | -1.49 | -0.89 |
| Ipca Laboratories | 0.03 | -1.53 | -4.50 | -7.24 | -13.62 | 14.38 | 4.62 |
| Ajanta Pharma | -0.82 | 5.36 | -4.53 | -1.72 | -10.35 | 26.38 | 19.81 |
| Gland Pharma | -3.69 | -5.21 | -6.25 | 27.51 | 7.24 | 1.75 | 0.09 |
Over the last one year, Gujarat Terce Laboratories has declined 44.16% compared to peers like Sun Pharmaceutical Industries (-2.20%), Divi's Laboratories (14.14%), Torrent Pharmaceuticals (22.74%). From a 5 year perspective, Gujarat Terce Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (27.90%) and Divi's Laboratories (13.94%).
Gujarat Terce Laboratories Financials
Gujarat Terce Laboratories Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 47.74 | 45.35 |
| 10 | 48.88 | 46.16 |
| 20 | 48.7 | 46.72 |
| 50 | 44.41 | 46.43 |
| 100 | 47.44 | 48.35 |
| 200 | 56.64 | 52.71 |
Gujarat Terce Laboratories Share Holding Pattern
In the latest quarter, Gujarat Terce Laboratories remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved up to 62.97% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Gujarat Terce Laboratories Corporate Actions
Date Time | Announcement |
|---|---|
| Nov 08, 2025, 10:34 PM IST | Guj. Terce Labor - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Nov 08, 2025, 8:50 PM IST | Guj. Terce Labor - Unaudited Standalone Financial Results Of The Company Forthe Second Quarter And Half Year Ended 30 Septemb |
| Nov 08, 2025, 8:42 PM IST | Guj. Terce Labor - Board Meeting Outcome for Board Meeting Outcome For Outcome Of The Board Meeting Held On 8 November 2025 |
| Nov 02, 2025, 8:05 PM IST | Guj. Terce Labor - Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone Financial Results Of The C |
| Oct 10, 2025, 5:51 AM IST | Guj. Terce Labor - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
About Gujarat Terce Laboratories
Gujarat Terce Laboratories Ltd. is a Public Limited Listed company incorporated on 28/03/1985 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24100GJ1985PLC007753 and registration number is 007753. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 50.20 Cr. and Equity Capital is Rs. 7.42 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address122/2, Ravi Estate, Gandhinagar District Gujarat 382729
- Contact
Management
- Mr. Natwarbhai P PrajapatiChairman
- Mr. Amrutbhai P PrajapatiWhole Time Director
- Mr. Aalap PrajapatManaging Director & CEO
- Mrs. Chhayaben A ShahIndependent Director
- Mr. Viplav S KhamarIndependent Director
- Mr. Surendra Kumar SharmaIndependent Director
- Mr. Navinchandra PatelIndependent Director
FAQs on Gujarat Terce Laboratories Share Price
What is the share price of Gujarat Terce Laboratories?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Gujarat Terce Laboratories is ₹45.03 as on Nov 13, 2025.
What kind of stock is Gujarat Terce Laboratories?
The Gujarat Terce Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Gujarat Terce Laboratories?
The market cap of Gujarat Terce Laboratories is ₹33.41 Cr as on Nov 13, 2025.
What are today's High and Low prices of Gujarat Terce Laboratories?
Today’s highest and lowest price of Gujarat Terce Laboratories are ₹46.49 and ₹43.56.
What are the 52 Week High and 52 Week Low of Gujarat Terce Laboratories?
The 52-week high/low is the highest and lowest price at which Gujarat Terce Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Gujarat Terce Laboratories is ₹92.22 and 52-week low of Gujarat Terce Laboratories is ₹37.20 as on Nov 13, 2025.
How has the Gujarat Terce Laboratories performed historically in terms of returns?
The Gujarat Terce Laboratories has shown returns of 2.22% over the past day, -20.41% for the past month, 7.16% over 3 months, -44.16% over 1 year, 37.29% across 3 years, and 40.83% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Gujarat Terce Laboratories?
P/E ratio of and PB ratio of Gujarat Terce Laboratories are 0.00 and 4.26 on Nov 13, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse